The body that recommends what drugs can and cannot be paid for now says a drug once hailed as a breakthrough is not "cost effective".
A man from Lincolnshire who won his fight against prostate cancer has joined the ranks of those calling for Arbiraterone to remain available:
More top news
Weather update with Kerrie Gosney.
Sam Burgess is ready to show what he can do in rugby union following his code switch, after defending his decision to leave league
Lunchtime weather update with Kerrie Gosney